Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema-Reference-Cited by-同舟云学术

Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema

Published:2023-03 Issue: Volume:29 Page:101788
ISSN:2451-9936
Container-title:American Journal of Ophthalmology Case Reports
language:en
Short-container-title:American Journal of Ophthalmology Case Reports

Author:

Hirano Takao^ORCID,Toriyama Yuichi,Takahashi Yoshiaki,Hoshiyama Ken,Murata Toshinori^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference16 articles.

1. HAWK and HARRIER: ninety-six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration;Dugel;Ophthalmology,2021

2. A randomized, double-masked, multicenter, phase III study assessing the efficacy and safety of brolucizumab versus aflibercept in patients with visual impairment due to diabetic macular edema (KITE);Garweg;Klin Monbl Augenheilkd,2020

3. KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema;Brown;Am J Ophthalmol,2022

4. Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration;Haug;Am J Ophthalmol Case Rep,2020

5. Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations;Jain;Am J Ophthalmol Case Rep,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laser flare photometry in eyes receiving brolucizumab intravitreal injections for age related macular degeneration;European Journal of Ophthalmology;2024-03-06

2. Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS);Expert Opinion on Drug Safety;2024-02-27

3. Flare levels after intravitreal injection of brolucizumab for diabetic macular edema;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-13

4. Safety and Efficacy of Brolucizumab in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy: A Systematic Review and Meta-Analysis;Seminars in Ophthalmology;2023-10-18

5. Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment—A Meta-Analysis and Systematic Review;Journal of Clinical Medicine;2023-07-14